Severe Community-Acquired Pneumonia

Catia Cillóniz; Cristina Dominedò; Adamanthia Liapikou; Antoni Torres

doi:10.1016/B978-0-12-801238-3.11487-4

Severe Community-Acquired Pneumonia

Catia Cillóniz, Cristina Dominedò, Adamanthia Liapikou, Antoni Torres

Producción científica: Libro o Capítulo del libro › Capítulo de Libro › revisión exhaustiva

Resumen

Although there is no general consensus on the definition of severe community-acquired pneumonia (SCAP), the most accepted criteria are based on the 2007 Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of CAP in adults. Since pulmonary and extra-pulmonary complications increase mortality and ICU admission, early recognition and management of SCAP are of pivotal importance. Severity scores and inflammatory biomarkers may be a complementary prognostic tool. An empiric antibiotic therapy based on international and local guidelines is associated with improved outcomes. The use of corticosteroids should be considered in SCAP with high inflammatory response.

Idioma original	Inglés estadounidense
Título de la publicación alojada	Encyclopedia of Respiratory Medicine, Second Edition
Editorial	Elsevier
Páginas	318-332
-	15
Volumen	5
ISBN (versión digital)	9780081027240
ISBN (versión impresa)	9780081027233
DOI	https://doi.org/10.1016/B978-0-12-801238-3.11487-4
Estado	Indizado - 1 ene. 2021
Publicado de forma externa	Sí

Nota bibliográfica

Publisher Copyright:
© 2022 Elsevier Ltd. All rights reserved

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1016/B978-0-12-801238-3.11487-4

Citar esto

@inbook{16beef371ff746c88b64eab9aaa3d0e1,

title = "Severe Community-Acquired Pneumonia",

abstract = "Although there is no general consensus on the definition of severe community-acquired pneumonia (SCAP), the most accepted criteria are based on the 2007 Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of CAP in adults. Since pulmonary and extra-pulmonary complications increase mortality and ICU admission, early recognition and management of SCAP are of pivotal importance. Severity scores and inflammatory biomarkers may be a complementary prognostic tool. An empiric antibiotic therapy based on international and local guidelines is associated with improved outcomes. The use of corticosteroids should be considered in SCAP with high inflammatory response.",

keywords = "Antibiotic, Corticosteroids, Diagnosis, Etiology, Mortality, Pneumonia, Sepsis, Septic shock, Severe pneumonia, Treatment",

author = "Catia Cill{\'o}niz and Cristina Domined{\`o} and Adamanthia Liapikou and Antoni Torres",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-801238-3.11487-4",

language = "American English",

isbn = "9780081027233",

volume = "5",

pages = "318--332",

booktitle = "Encyclopedia of Respiratory Medicine, Second Edition",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Severe Community-Acquired Pneumonia

AU - Cillóniz, Catia

AU - Dominedò, Cristina

AU - Liapikou, Adamanthia

AU - Torres, Antoni

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Although there is no general consensus on the definition of severe community-acquired pneumonia (SCAP), the most accepted criteria are based on the 2007 Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of CAP in adults. Since pulmonary and extra-pulmonary complications increase mortality and ICU admission, early recognition and management of SCAP are of pivotal importance. Severity scores and inflammatory biomarkers may be a complementary prognostic tool. An empiric antibiotic therapy based on international and local guidelines is associated with improved outcomes. The use of corticosteroids should be considered in SCAP with high inflammatory response.

AB - Although there is no general consensus on the definition of severe community-acquired pneumonia (SCAP), the most accepted criteria are based on the 2007 Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of CAP in adults. Since pulmonary and extra-pulmonary complications increase mortality and ICU admission, early recognition and management of SCAP are of pivotal importance. Severity scores and inflammatory biomarkers may be a complementary prognostic tool. An empiric antibiotic therapy based on international and local guidelines is associated with improved outcomes. The use of corticosteroids should be considered in SCAP with high inflammatory response.

KW - Antibiotic

KW - Corticosteroids

KW - Diagnosis

KW - Etiology

KW - Mortality

KW - Pneumonia

KW - Sepsis

KW - Septic shock

KW - Severe pneumonia

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85143101837&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-801238-3.11487-4

DO - 10.1016/B978-0-12-801238-3.11487-4

M3 - Chapter

AN - SCOPUS:85143101837

SN - 9780081027233

VL - 5

SP - 318

EP - 332

BT - Encyclopedia of Respiratory Medicine, Second Edition

PB - Elsevier

ER -

Severe Community-Acquired Pneumonia

Resumen

Nota bibliográfica

ODS de las Naciones Unidas

Acceder al documento

Huella

Citar esto